Altria
MO
$74.21
+1.62%
Altria Group, Inc. is a leading U.S. tobacco company that manufactures and sells cigarettes, smokeless tobacco, machine-made cigars, and reduced-risk products through subsidiaries like Philip Morris USA, U.S. Smokeless Tobacco, and Njoy Holdings. As the dominant player in the U.S. tobacco market, its Marlboro brand commands a 40% market share, and it also holds strategic stakes in Anheuser-Busch InBev and Cronos Group. The current investor narrative centers on Altria's transition toward smoke-free alternatives, including its Njoy vaping acquisition and heated tobacco joint venture, while managing declining cigarette volumes and defending its high dividend yield. Recent news highlights the stock's attractive yield and potential payout increases, balanced against ongoing regulatory and litigation risks.…
MO
Altria
$74.21
Related headlines
MO 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Altria's 12-month outlook, with a consensus price target around $70.64 and implied upside of -4.8% versus the current price.
Average Target
$70.64
0 analysts
Implied Upside
-4.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$59 - $82
Analyst target range
Altria is covered by 11 analysts, with a consensus recommendation of 'hold' (mean rating 2.62 on a 1-5 scale where 1 is strong buy). The average target price is $70.64, implying a 4.8% downside from the current price of $74.21. The distribution shows 5 buy ratings, 4 hold ratings, and 2 sell/underweight ratings, indicating a mixed sentiment. Recent actions include UBS maintaining a Buy (July 2026) and Barclays reiterating Underweight (May 2026), reflecting divergent views. The target range spans from a low of $59.00 to a high of $82.00. The high target of $82.00 assumes successful smoke-free transition and multiple expansion, while the low target of $59.00 prices in margin compression and litigation setbacks. The wide spread of $23.00 (39% of the low target) signals high uncertainty among analysts. The consensus leans neutral, with the average target below the current price, suggesting limited near-term upside potential despite strong recent momentum.
Drowning in data?
Find the real signal!
Bulls vs Bears: MO Investment Factors
Altria presents a mixed investment case. On the bull side, its 7.2% dividend yield, strong revenue growth (20.1% YoY), high net margins (40.2%), low beta (0.49), and robust free cash flow ($8.6B TTM) make it an attractive income and defensive play. However, bears point to declining cigarette volumes, negative equity, analyst consensus hold with downside to the average target ($70.64), low current ratio (0.61), and regulatory risks. The most critical tension is whether Altria can successfully transition to smoke-free products to offset volume declines while maintaining its dividend. If the transition gains traction, the stock could re-rate higher; if it fails, the dividend may become unsustainable. Currently, the bear case has slightly stronger evidence given the structural decline and analyst caution, but the high yield provides a margin of safety.
Bullish
- High Dividend Yield of 7.2%: Altria offers a dividend yield of 7.2%, well above the S&P 500 average. The payout ratio is 100.2%, indicating the dividend is fully covered by earnings, and recent news suggests potential payout increases, supporting income-focused investors.
- Strong Revenue Growth of 20.1% YoY: Q1 2026 revenue grew 20.1% year-over-year to $5.428 billion, driven by pricing power and smokeable product sales. This growth outpaces the consumer defensive sector, demonstrating the company's ability to generate top-line expansion despite volume declines.
- Excellent Profitability with 40.2% Net Margin: Net margin of 40.2% in Q1 2026 is significantly above the industry average, reflecting strong pricing and cost control. Operating margin of 54.5% further underscores operational efficiency, supporting robust cash flow generation.
- Low Beta of 0.49 Provides Defensive Qualities: With a beta of 0.49, Altria is much less volatile than the market, making it a defensive holding. The stock has outperformed the S&P 500 over the past year (up 28% vs 18.4%), appealing to risk-averse investors.
Bearish
- Declining Cigarette Volumes and Structural Headwinds: Despite revenue growth, cigarette volumes continue to decline due to health awareness and regulation. The company's core product faces secular decline, and its smoke-free transition (Njoy, heated tobacco) has yet to offset volume losses meaningfully.
- Negative Equity and High Debt Levels: Debt-to-equity ratio of -7.34 indicates negative shareholders' equity due to extensive share buybacks and dividends. This financial structure increases risk during downturns, as the company has limited equity cushion.
- Analyst Consensus Hold with Downside to Average Target: The average analyst target of $70.64 implies a 4.8% downside from the current price of $74.21. With 4 hold and 2 sell ratings out of 11 analysts, sentiment is cautious, suggesting limited near-term upside.
- Low Current Ratio of 0.61 Indicates Liquidity Risk: A current ratio of 0.61 means current liabilities exceed current assets, which could strain short-term liquidity. While typical for tobacco companies with steady cash flows, it leaves little buffer for unexpected obligations.
MO Technical Analysis
Altria is in a sustained uptrend, with the stock up 27.99% over the past year, significantly outperforming the S&P 500's 18.35% gain. The current price of $74.21 sits at 98.6% of its 52-week range ($54.70–$75.28), indicating the stock is near its highs and reflecting strong momentum. This positioning suggests bullish sentiment but also raises caution about potential overextension, as the stock is trading just 1.4% below its 52-week high. Short-term momentum is accelerating, with a 1-month gain of 7.63% and a 3-month gain of 15.65%, both outpacing the S&P 500's respective returns of 0.31% and 4.67%. The relative strength indicators (1-month: 7.32, 3-month: 10.98) confirm strong recent outperformance, and there is no divergence from the longer-term uptrend, reinforcing a bullish technical picture. Key support lies at the 52-week low of $54.70, while resistance is at the 52-week high of $75.28. A breakout above $75.28 would signal continued upside momentum, while a breakdown below $54.70 would indicate a trend reversal. With a beta of 0.494, Altria is significantly less volatile than the market, making it a defensive holding that tends to hold up better during downturns but may lag in strong rallies.
Beta
0.49
0.49x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$55-$75
Price range past year
Annual Return
+28.0%
Cumulative gain past year
| Period | MO Return | S&P 500 |
|---|---|---|
| 1m | +7.6% | -0.5% |
| 3m | +15.6% | +4.9% |
| 6m | +20.2% | +9.7% |
| 1y | +28.0% | +18.4% |
| ytd | +29.5% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MO Fundamental Analysis
Revenue growth has been robust, with Q1 2026 revenue of $5.428 billion up 20.12% year-over-year, driven by strong performance in smokeable products ($4.758 billion) and smokeless products ($669 million). However, the multi-quarter trend shows some volatility: Q4 2025 revenue was $5.846 billion, while Q3 2025 was $5.251 billion, indicating sequential deceleration. The growth is supported by pricing power and mix shift, but volume declines in traditional cigarettes remain a headwind. Profitability is excellent, with Q1 2026 net income of $2.183 billion and a net margin of 40.2%, well above the industry average. Gross margin was 64.6% in Q1 2026, slightly down from 72.8% in Q2 2025, but still high. Operating margin of 54.5% reflects strong pricing and cost control, though the company faces ongoing litigation expenses. The balance sheet shows a debt-to-equity ratio of -7.34 (negative equity due to share buybacks and dividends), which is common for mature tobacco companies. Free cash flow generation is strong at $8.623 billion TTM, supporting a high dividend payout ratio of 100.2%. However, the current ratio of 0.61 indicates limited short-term liquidity, though this is typical for the industry given steady cash flows.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+20.1%
YoY Comparison
Gross Margin
64.6%
Latest Quarter
Free Cash Flow
$8.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MO Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 14.03x, while the forward P/E is 12.63x, implying the market expects earnings growth over the next year. The gap between trailing and forward P/E suggests modest growth expectations, consistent with a mature industry. Compared to the consumer defensive sector average P/E of approximately 22x, Altria trades at a 36% discount, reflecting its declining cigarette volumes and regulatory overhangs. This discount may be justified by its lower growth profile, but the stock's high dividend yield (7.2%) and strong cash flow provide a margin of safety. Historically, Altria's trailing P/E has ranged from 7.3x to 23.8x over the past five years. The current 14.0x is near the middle of this range, suggesting the stock is fairly valued relative to its own history. It is not at extreme levels, indicating that the market is pricing in a balanced outlook between its defensive income appeal and structural challenges.
PE
14.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Altria's negative equity (debt-to-equity -7.34) and high payout ratio (100.2%) leave little financial flexibility. The current ratio of 0.61 indicates potential liquidity strain, though steady cash flows mitigate this. Revenue concentration in cigarettes (88% of Q1 2026 revenue from smokeable products) exposes the company to volume declines, which have been secular. Any disruption in cash flow could threaten the dividend, which is a key investor attraction.
Market & Competitive Risks: The stock trades at a trailing P/E of 14.0x, a 36% discount to the consumer defensive sector average of 22x, reflecting structural challenges. However, with a beta of 0.49, it is less sensitive to macro downturns. Competitive risks include the rise of e-cigarettes and nicotine pouches from players like Juul and British American Tobacco. Regulatory actions, such as FDA's proposed menthol ban, could significantly impact Marlboro's 40% market share. Recent news highlights potential dividend increases, but this may not offset volume headwinds.
Worst-Case Scenario: A severe regulatory setback (e.g., nationwide flavor ban) combined with accelerating volume declines could pressure margins and force a dividend cut. In this scenario, the stock could fall to the 52-week low of $54.70, representing a 26.3% decline from the current price of $74.21. The analyst low target of $59.00 implies a 20.5% downside. Historical max drawdown of -19.15% suggests similar magnitude. An investor could lose up to 26% in an adverse scenario.
